欢迎来到天天文库
浏览记录
ID:46401663
大小:70.00 KB
页数:3页
时间:2019-11-23
《卡托普利联合格列喹酮治疗糖尿病肾病的临床观察》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、卡托普利联合格列嗤酮治疗糖尿病肾病的临床观察[摘耍]冃的:探讨R托普利联合格列唾酮(糖适平)治疗糖尿病肾病的效果。方法:选择血压正常的糖尿病肾病患者90例,将其随机分为观察纟F1与对照纽.,每纽•各45例,对照组采用格列峰酮控制血糖,观察组在对照组基础上加用卡托普利,对比两组空腹血糖、蛋口尿、血肌酹情况。结果:治疗前两组患者血糖、尿蛋白排泄率及血肌阡水平比较,差界无统计学意义(P>0.05),治疗2个月后,两组空腹血糖、尿蛋白排泄量、血肌酹水平治疗后均显著下降,差异有高度统计学意义(PV0.01),治疗后两组血糖比较,差异无统计学意义(P>0.0
2、5),观察组尿蛋白排泄量及血肌酎水平显著低于对照纟R,差异有高度统计学意义(P3、nDepartmentofInternalMedicine,MaternalandChildHealthHospitalinGuangdongProvince,Guangzhou510010,China[Abstract]Objective:ToinvostigatotheclinicaleffectofCaptopri1combinedGliquidoneinthetreatmentofdiabeticnephropathy(DN).Methods:90casesofpatientswithDNandnormalbloodpressurewer4、eselectedandrandomlydividedintoobservationgroupandcontrolgroup,with45casesineachgroup.Gliquidonewastakenforcontrollingbloodsugarincontrolgroup,Captoprilwastakeninobservationgrouponbasisofcontrolgroup・Thelevelofbloodsugar,urineproteinandureanitrogenwascontrastedbetweencontrolg5、roupandobservationgroup・Results:Beforetreatment,thedifferencesof1evelofbloodsugar,urineproteinandureanitrogenbetweencontrolgroupandobservationgroupwerenosignificant(P>0.05).2monthsaftertreatment,thelevelofbloodsugar,urineproteinandureanitrogendecreased,thedifferencoswerehighl6、ysignificant(PV0.01),thedifferenccofthelevelofbloodsugarbetweenthetwogroupswasnosignificant(P>0.05),thelevelofurineproteinandureanitrogenwere1owerinobservationgroupthanthoseincontrolgroup,withhighlysignificantdifferences(PV0.01).Conelusion:CaptoprilcombinedwithGliquidoneonDNc7、anobtainbettercurativeeffect.[Keywords]Diabeticnephropathy;Captopri1;Gliquidone糖尿病肾病(diabeticnephropathy,DN)是糊尿病的常见并发症,是糖尿病全身性微血管病变表现之一,临床特征为蛋白尿,渐进性肾功能损害。近年來其临床发病率有升高趋势,严重影响糖尿病患者的生活质量,国內有报道称,糖尿病肾病町导致尿毒症的发生⑴。如何在糖尿病治疗屮既能有效降低血糖又可有效保护肾功能逐渐成为研究重点。笔者应用格列座酮(糖适平)联合卡托普利治疗45例糖凍病肾病患者,取得8、了较好的效果。现报道如下:1资料与方法1.1一般资料选取我院2008年1月〜2010年10月收治的2型糖丿來病肾病患者90例作为研究对象
3、nDepartmentofInternalMedicine,MaternalandChildHealthHospitalinGuangdongProvince,Guangzhou510010,China[Abstract]Objective:ToinvostigatotheclinicaleffectofCaptopri1combinedGliquidoneinthetreatmentofdiabeticnephropathy(DN).Methods:90casesofpatientswithDNandnormalbloodpressurewer
4、eselectedandrandomlydividedintoobservationgroupandcontrolgroup,with45casesineachgroup.Gliquidonewastakenforcontrollingbloodsugarincontrolgroup,Captoprilwastakeninobservationgrouponbasisofcontrolgroup・Thelevelofbloodsugar,urineproteinandureanitrogenwascontrastedbetweencontrolg
5、roupandobservationgroup・Results:Beforetreatment,thedifferencesof1evelofbloodsugar,urineproteinandureanitrogenbetweencontrolgroupandobservationgroupwerenosignificant(P>0.05).2monthsaftertreatment,thelevelofbloodsugar,urineproteinandureanitrogendecreased,thedifferencoswerehighl
6、ysignificant(PV0.01),thedifferenccofthelevelofbloodsugarbetweenthetwogroupswasnosignificant(P>0.05),thelevelofurineproteinandureanitrogenwere1owerinobservationgroupthanthoseincontrolgroup,withhighlysignificantdifferences(PV0.01).Conelusion:CaptoprilcombinedwithGliquidoneonDNc
7、anobtainbettercurativeeffect.[Keywords]Diabeticnephropathy;Captopri1;Gliquidone糖尿病肾病(diabeticnephropathy,DN)是糊尿病的常见并发症,是糖尿病全身性微血管病变表现之一,临床特征为蛋白尿,渐进性肾功能损害。近年來其临床发病率有升高趋势,严重影响糖尿病患者的生活质量,国內有报道称,糖尿病肾病町导致尿毒症的发生⑴。如何在糖尿病治疗屮既能有效降低血糖又可有效保护肾功能逐渐成为研究重点。笔者应用格列座酮(糖适平)联合卡托普利治疗45例糖凍病肾病患者,取得
8、了较好的效果。现报道如下:1资料与方法1.1一般资料选取我院2008年1月〜2010年10月收治的2型糖丿來病肾病患者90例作为研究对象
此文档下载收益归作者所有